| Physicochemical and preclinical evaluation of a novel buccal measles vaccine RP Gala, C Popescu, GT Knipp, RR McCain, RV Ubale, R Addo, ... AAPS PharmSciTech 18 (2), 283-292, 2017 | 61 | 2017 |
| Formulation and Characterization of Atropine Sulfate in Albumin–Chitosan Microparticles for In Vivo Ocular Drug Delivery RT Addo, KG Yeboah, RC Siwale, A Siddig, A Jones, RV Ubale, J Akande, ... Journal of pharmaceutical sciences 104 (5), 1677-1690, 2015 | 40 | 2015 |
| Formulation of meningococcal capsular polysaccharide vaccine-loaded microparticles with robust innate immune recognition RV Ubale, MJ D'souza, DT Infield, NA McCarty, SM Zughaier Journal of microencapsulation 30 (1), 28-41, 2013 | 35 | 2013 |
| Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles PN Shastri, RV Ubale, MJ D'Souza Drug development and industrial pharmacy 39 (2), 164-175, 2013 | 28 | 2013 |
| Liposome-Based Nanomedicine Therapeutics for Rheumatoid Arthritis M Rahman, S Beg, F Anwar, V Kumar, R Ubale, RT Addo, R Ali, S Akhter Critical Reviews™ in Therapeutic Drug Carrier Systems 34 (4), 2017 | 21 | 2017 |
| Induction of Death Receptor CD95 and Co-stimulatory Molecules CD80 and CD86 by Meningococcal Capsular Polysaccharide-Loaded Vaccine Nanoparticles RV Ubale, RP Gala, SM Zughaier, MJ D’Souza The AAPS journal 16 (5), 986-993, 2014 | 20 | 2014 |
| Development and Validation of a UPLC method for rapid and simultaneous analysis of proton pump inhibitors RT Addo, K Davis, R Ubale, JS Owen, EB Watkins AAPS PharmSciTech 16 (1), 30-34, 2015 | 14 | 2015 |
| Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer Therapies MJ D’Souza, RP Gala, RV Ubale, B D’Souza, TP Vo, AC Parenky, ... Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies …, 2015 | 10 | 2015 |
| The effect of antisense to NF-κB in an albumin microsphere formulation on the progression of left-ventricular remodeling associated with chronic volume overload in rats N Patel, RT Addo, R Ubale, MN Uddin, M D'Souza, L Jobe Journal of drug targeting 22 (9), 796-804, 2014 | 10 | 2014 |
| Design of Experiments: A Valuable “Quality by Design” Tool in Formulation Development LP Kolluru, RP Gala, PN Shastri, RV Ubale Nanoparticulate Vaccine Delivery Systems 61, 2015 | 8 | 2015 |
| Pulmonary Administration of Microparticulate Antisense Oligonucleotide (ASO) for the Treatment of Lung Inflammation RV Ubale, PN Shastri, C Oettinger, MJ D’Souza AAPS PharmSciTech 19 (4), 1908-1919, 2018 | 5 | 2018 |
| Background of Ocular Drug Delivery OA Bamiro, RV Ubale, RT Addo Ocular Drug Delivery: Advances, Challenges and Applications, 1-9, 2016 | 5 | 2016 |
| Approaches and issues towards development of efficient mucosal vaccines against pneumonia D Devineni, S Paulos, R Ubale, B Rayaprolu, R Palaniappan Clinical Research and Regulatory Affairs 26 (3), 39-49, 2009 | 5 | 2009 |
| Development of Non-Conjugated Meningitis Particulate vaccine RP Gala, RV Ubale, MJ D’Souza, SM Zughaier Nanoparticulate Vaccine Delivery Systems, 1st ed.; CRC Press: Boca Raton, FL …, 2015 | 2* | 2015 |
| In Vitro and in Vivo Evaluation of Ocular Drugs and Delivery Systems RV Ubale, RT Addo Ocular Drug Delivery: Advances, Challenges and Applications, 101-115, 2016 | 1 | 2016 |
| Patient Satisfaction and Patients' Family or Significant Other Perceptions After OnabotulinumtoxinA Treatment: A Prospective Cross-Sectional Study JR Montes, RV Ubale Dermatologic Surgery 45 (8), 1069-1079, 2019 | | 2019 |
| Development of Non-Conjugated Meningitis Particulate Vaccine RP Gala, RV Ubale, MJ D’Souza, SM Zughaierc | | 2015 |
| Development of Spray Dried Microparticulate Delivery Systems for Vaccines and Oligonucleotides RV Ubale Mercer University, 2013 | | 2013 |
| Conjugation free oral microparticulate meningitis vaccine formulation and evaluation. RP Gala, RV Ubale, SM Zughair, MJ Dsouza | | |
| Nanotherapeutic targeting in management of arthritis using liposomes: The-state-of-the-art M Rahman, S Beg, F Anwar, V Kumar, R Ubale, RT Addo, R Ali, S Akhtar Critical Reviews™ in Therapeutic Drug Carrier Systems, 0 | | |
